A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.
Life Sci
; 268: 118959, 2021 Mar 01.
Article
in English
| MEDLINE | ID: covidwho-988728
Semantic information from SemMedBD (by NLM)
1. Disease ASSOCIATED_WITH Mutation
2. Mutation PROCESS_OF Cystic Fibrosis Transmembrane Conductance Regulator
3. Cystic Fibrosis AFFECTS Inflammatory Response
4. MULTISYSTEM DISORDER AFFECTS Comorbidity
5. Respiration Disorders COEXISTS_WITH Cystic Fibrosis
6. Epithelium LOCATION_OF Destructive procedure (surgical)
7. Glycoproteins AFFECTS Disease
8. paired basic amino acid cleaving enzyme ADMINISTERED_TO Cells
9. Disease ASSOCIATED_WITH Mutation
10. Mutation PROCESS_OF Cystic Fibrosis Transmembrane Conductance Regulator
11. Cystic Fibrosis AFFECTS Inflammatory Response
12. MULTISYSTEM DISORDER AFFECTS Comorbidity
13. Respiration Disorders COEXISTS_WITH Cystic Fibrosis
14. Epithelium LOCATION_OF Destructive procedure (surgical)
15. Glycoproteins AFFECTS Disease
16. paired basic amino acid cleaving enzyme ADMINISTERED_TO Cells
ABSTRACT
Cystic fibrosis (CF) is an autosomal recessive disease which involves the mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF involves in the inflammatory processes and is considered as a multisystem disorder that is not confined to lungs, but it also affects other vital organs that leads to numerous co-morbidities. The respiratory disorder in the CF results in mortality and morbidity which is characterized by series of serious events involving mucus hypersecretion, microbial infections, airways obstruction, inflammation, destruction of epithelium, tissue remodeling and terminal lung diseases. Mucins are the high molecular weight glycoproteins important for the viscoelastic properties of the mucus, play a significant role in the disease mechanisms. Determining the functional association between the CFTR and mucins might help to identify the putative target for specific therapeutic approach. In fact, furin enzyme which helps in the entry of novel COVID-19 virus into the cell, is upregulated in CF and this can also serve as a potential target for CF treatment. Moreover, the use of nano-formulations for CF treatment is an area of research being widely studied as they have also demonstrated promising outcomes. The in-depth knowledge of non-coding RNAs like miRNAs and lncRNAs and their functional association with CFTR gene expression and mutation can provide a different range of opportunity to identify the promising therapeutic approaches for CF.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cystic Fibrosis Transmembrane Conductance Regulator
/
Cystic Fibrosis
/
COVID-19
Limits:
Animals
/
Humans
Language:
English
Journal:
Life Sci
Year:
2021
Document Type:
Article
Affiliation country:
J.lfs.2020.118959
Similar
MEDLINE
...
LILACS
LIS